首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2385907篇
  免费   195490篇
  国内免费   4225篇
耳鼻咽喉   34367篇
儿科学   73062篇
妇产科学   63244篇
基础医学   336300篇
口腔科学   67867篇
临床医学   216944篇
内科学   470396篇
皮肤病学   48192篇
神经病学   201774篇
特种医学   96410篇
外国民族医学   886篇
外科学   361630篇
综合类   56520篇
现状与发展   1篇
一般理论   992篇
预防医学   191945篇
眼科学   55586篇
药学   178173篇
  5篇
中国医学   4375篇
肿瘤学   126953篇
  2018年   24445篇
  2016年   20751篇
  2015年   23461篇
  2014年   33793篇
  2013年   51251篇
  2012年   69283篇
  2011年   72836篇
  2010年   42834篇
  2009年   41178篇
  2008年   69246篇
  2007年   73580篇
  2006年   74467篇
  2005年   72514篇
  2004年   69800篇
  2003年   67477篇
  2002年   66705篇
  2001年   112731篇
  2000年   116825篇
  1999年   98609篇
  1998年   27995篇
  1997年   25638篇
  1996年   25580篇
  1995年   24712篇
  1994年   23233篇
  1993年   21636篇
  1992年   79602篇
  1991年   76590篇
  1990年   73772篇
  1989年   71020篇
  1988年   65982篇
  1987年   64948篇
  1986年   61471篇
  1985年   58546篇
  1984年   44386篇
  1983年   37785篇
  1982年   22957篇
  1981年   20398篇
  1980年   19114篇
  1979年   41415篇
  1978年   29064篇
  1977年   24413篇
  1976年   22915篇
  1975年   24030篇
  1974年   29719篇
  1973年   28133篇
  1972年   26316篇
  1971年   24220篇
  1970年   22806篇
  1969年   21134篇
  1968年   19204篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Red cell exchange (RCE) is a common procedure in adults with sickle cell disease (SCD). Implantable dual lumen Vortex (DLV) ports can be used for RCE in patients with poor peripheral venous access. We performed a retrospective cohort study of RCE procedures performed in adults with SCD. The main objective of the study was to compare the inlet speed, duration of procedures and rate of complications performed through DLV ports to those performed through temporary central venous and peripheral catheters. Twenty‐nine adults with SCD underwent a total of 318 RCE procedures. Twenty adults had DLV ports placed and 218 procedures were performed using DLV ports. Mean length of follow‐up after DLV port placement was 397 ± 263 days. Six DLV ports were removed due to infection and 1 for malfunction after a mean of 171 ± 120 days. Compared to temporary central venous and peripheral catheters, DLV port procedures had a greater rate of procedural complications, a longer duration, and a lower inlet speed (all P < 0.01). When accounting for the maximum allowable inlet speed to avoid citrate toxicity, 40% of DLV port procedures were greater than 10% below maximum speed, compared to 7 and 14% of procedures performed through temporary central venous and peripheral catheters (P < 0.0001). In conclusion, DLV ports can be used for RCE in adults with SCD, albeit with more procedural complications and longer duration. The smaller internal diameter and longer catheter of DLV ports compared to temporary central venous catheters likely accounts for the differences noted. J. Clin. Apheresis 30:353–358, 2015. © 2015 Wiley Periodicals, Inc.  相似文献   
52.
53.
54.
55.
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (= 768 SMV/PR,= 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity.  相似文献   
56.
57.
58.
59.
60.
To evaluate the changes in alveolar contour after guided bone regeneration (GBR) with two different combinations of biomaterials in dehiscence defects arou  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号